Table of Contents

2019-2024 Global Auto-Injectors Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Auto-Injectors Consumption 2014-2024
  • 2.1.2 Auto-Injectors Consumption CAGR by Region
• 2.2 Auto-Injectors Segment by Type
  • 2.2.1 Disposable Auto-Injectors
  • 2.2.2 Reusable Auto-Injectors
• 2.3 Auto-Injectors Consumption by Type
  • 2.3.1 Global Auto-Injectors Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Auto-Injectors Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Auto-Injectors Sale Price by Type (2014-2019)
• 2.4 Auto-Injectors Segment by Application
  • 2.4.1 Anaphylaxis
  • 2.4.2 Multiple Sclerosis
  • 2.4.3 Rheumatoid Arthritis
  • 2.4.4 Others
• 2.5 Auto-Injectors Consumption by Application
  • 2.5.1 Global Auto-Injectors Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Auto-Injectors Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Auto-Injectors Sale Price by Application (2014-2019)

3 Global Auto-Injectors by Players

• 3.1 Global Auto-Injectors Sales Market Share by Players
  • 3.1.1 Global Auto-Injectors Sales by Players (2017-2019)
  • 3.1.2 Global Auto-Injectors Sales Market Share by Players (2017-2019)
• 3.2 Global Auto-Injectors Revenue Market Share by Players
  • 3.2.1 Global Auto-Injectors Revenue by Players (2017-2019)
  • 3.2.2 Global Auto-Injectors Revenue Market Share by Players (2017-2019)
• 3.3 Global Auto-Injectors Sale Price by Players
• 3.4 Global Auto-Injectors Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Auto-Injectors Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Auto-Injectors Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Auto-Injectors by Regions

• 4.1 Auto-Injectors by Regions
  • 4.1.1 Global Auto-Injectors Consumption by Regions
  • 4.1.2 Global Auto-Injectors Value by Regions
• 4.2 Americas Auto-Injectors Consumption Growth
• 4.3 APAC Auto-Injectors Consumption Growth
• 4.4 Europe Auto-Injectors Consumption Growth
• 4.5 Middle East & Africa Auto-Injectors Consumption Growth

5 Americas

• 5.1 Americas Auto-Injectors Consumption by Countries
  • 5.1.1 Americas Auto-Injectors Consumption by Countries (2014-2019)
  • 5.1.2 Americas Auto-Injectors Value by Countries (2014-2019)
• 5.2 Americas Auto-Injectors Consumption by Type
• 5.3 Americas Auto-Injectors Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Auto-Injectors Consumption by Countries
  • 6.1.1 APAC Auto-Injectors Consumption by Countries (2014-2019)
  • 6.1.2 APAC Auto-Injectors Value by Countries (2014-2019)
• 6.2 APAC Auto-Injectors Consumption by Type
• 6.3 APAC Auto-Injectors Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Auto-Injectors by Countries
  • 7.1.1 Europe Auto-Injectors Consumption by Countries (2014-2019)
  • 7.1.2 Europe Auto-Injectors Value by Countries (2014-2019)
• 7.2 Europe Auto-Injectors Consumption by Type
• 7.3 Europe Auto-Injectors Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Auto-Injectors by Countries
  • 8.1.1 Middle East & Africa Auto-Injectors Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Auto-Injectors Value by Countries (2014-2019)
• 8.2 Middle East & Africa Auto-Injectors Consumption by Type
• 8.3 Middle East & Africa Auto-Injectors Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Auto-Injectors Distributors
• 10.3 Auto-Injectors Customer

11 Global Auto-Injectors Market Forecast

• 11.1 Global Auto-Injectors Consumption Forecast (2019-2024)
• 11.2 Global Auto-Injectors Forecast by Regions
  • 11.2.1 Global Auto-Injectors Forecast by Regions (2019-2024)
  • 11.2.2 Global Auto-Injectors Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Auto-Injectors Forecast by Type
• 11.8 Global Auto-Injectors Forecast by Application

12 Key Players Analysis

• 12.1 Mylan
  • 12.1.1 Company Details
  • 12.1.2 Auto-Injectors Product Offered
  • 12.1.3 Mylan Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Mylan News
• 12.2 BD
  • 12.2.1 Company Details
  • 12.2.2 Auto-Injectors Product Offered
  • 12.2.3 BD Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 BD News
• 12.3 Johnson & Johnson
  • 12.3.1 Company Details
  • 12.3.2 Auto-Injectors Product Offered
  • 12.3.3 Johnson & Johnson Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Johnson & Johnson News
• 12.4 Amgen Inc.
  • 12.4.1 Company Details
  • 12.4.2 Auto-Injectors Product Offered
  • 12.4.3 Amgen Inc. Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Amgen Inc. News
• 12.5 Eli Lilly
  • 12.5.1 Company Details
  • 12.5.2 Auto-Injectors Product Offered
  • 12.5.3 Eli Lilly Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Eli Lilly News
• 12.6 Biogen Idec
  • 12.6.1 Company Details
  • 12.6.2 Auto-Injectors Product Offered
  • 12.6.3 Biogen Idec Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Biogen Idec News
• 12.7 Bayer
  • 12.7.1 Company Details
  • 12.7.2 Auto-Injectors Product Offered
  • 12.7.3 Bayer Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Bayer News
• 12.8 Meridian (Pfizer)
  • 12.8.1 Company Details
  • 12.8.2 Auto-Injectors Product Offered
  • 12.8.3 Meridian (Pfizer) Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Meridian (Pfizer) News
• 12.9 Ypsomed Holding
  • 12.9.1 Company Details
  • 12.9.2 Auto-Injectors Product Offered
  • 12.9.3 Ypsomed Holding Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Ypsomed Holding News
• 12.10 Kaleo, Inc.
  • 12.10.1 Company Details
  • 12.10.2 Auto-Injectors Product Offered
  • 12.10.3 Kaleo, Inc. Auto-Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Kaleo, Inc. News
• 12.11 Owen Mumford
• 12.12 Antares Pharma, Inc.
• 12.13 Medeca Pharma AB

13 Research Findings and Conclusion

Auto-injector is a medical device designed to deliver a dose of a particular drug.
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price.
The classification of Auto-Injectors includes reusable Auto-Injectors and disposable Auto-Injectors, and the proportion of disposable Auto-Injectors in 2017 is about 62.7%, and the proportion is in increasing trend from 2013 to 2017.
Auto-injectors are pen like devices used to deliver a fixed dose of drug to patients and are intended for self-administration. Auto-injectors are gradually becoming the gold-standard in the treatment of various indications like anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. The most proportion of Auto-Injectors is used for Anaphylaxis, and the proportion in 2017 is 56.9%.
North America is the largest consumption place, with a consumption market share nearly 59.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. China is also an important sales region.
Market competition is not intense. Mylan, BD, Johnson & Johnson, Amgen Inc., etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Auto-Injectors market will register a 7.7% CAGR in terms of revenue, the global market size will reach US$ 2590 million by 2024, from US$ 1660 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Auto-Injectors business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Auto-Injectors market by product type, application, key manufacturers and key regions and countries.

This study considers the Auto-Injectors value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Disposable Auto-Injectors
Reusable Auto-Injectors
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mylan
BD
Johnson & Johnson
Amgen Inc.
Eli Lilly
Biogen Idec
Bayer
Meridian (Pfizer)
Ypsomed Holding
Kaleo, Inc.
Owen Mumford
Antares Pharma, Inc.
Medeca Pharma AB

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Auto-Injectors consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Auto-Injectors market by identifying its various subsegments.
Focuses on the key global Auto-Injectors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Auto-Injectors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Auto-Injectors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.